WHO ICTRP trial
A comparative clinical study to evaluate a product in Iron Deficiency Subjects
CTRI/2023/06/053923 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/06/053923 |
|---|---|
| Public title | A comparative clinical study to evaluate a product in Iron Deficiency Subjects |
| Scientific title | A Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, Comparative Evaluation of HIA-10-23 in Iron Deficient Population. |
| Primary sponsor | Akay Natural Ingredients Pvt. Ltd. |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: E611- Iron deficiency |
| Interventions | Intervention1: HIA-10-23: Oral dose, 500 mg/day for 120 days Control Intervention1: Placebo: Oral dose, 500 mg/day for 120 days |
| Registration date | Jun 15, 2023 |
| Target size | 90 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: